Matt Henriksen

Yeah.

And I know recently you've had your Series B financing.

So how much of that gets covered by that initial financing?

Yeah.

And then, you know,

Let's close out the episode because, you know, there's a lot of interesting developments going on.

And, you know, basically what you just talked about with, you know, the coronary as being a very important market for you guys.

And let me just also add, you know, there's Shockwave, but, you know, Boston bought Bolt.

Abbott is coming out with their coronary.

There's a few other private companies out there.

So the competitive landscape is evolving.

Combining that technology, that development, the market development with the competitive landscape, how do you see IVL playing out over the next five years?

Well, especially when you're down though, you want to make sure it's done before having to go back down or either go into the heart again or go all the way down below the knee again.

Measure twice, throw the big bag of ice on the ground once.

Exactly.

Oh, yeah.

Well, hey, Mark, thank you so much for joining us today.

Always enjoying hearing the story and looking forward to seeing how 2026 and beyond plays out for you guys.

And thank you to our producers, Mariam Thawele and Aditya Simani, for all the behind-the-scene work.

And thank you to our listeners for tuning in today.